Humana beat Q3 estimates with $3.24 EPS and $32.65 billion sales, reaffirming 2025 earnings guidance at $17 per share despite Medicare declines.
Humana beat Q3 estimates with $3.24 EPS and $32.65 billion sales, reaffirming 2025 earnings guidance at $17 per share despite Medicare declines.